November 16, 2022Current Oncology66 citationsOpen Access
Stereotactic Radiotherapy after Incomplete Transarterial (Chemo-) Embolization (TAE) versus Exclusive TAE or TACE for Treatment of Inoperable HCC: A Phase III Trial (NCT02323360)
Key points are not available for this paper at this time.
Abstract
SBRT is an effective treatment option in patients affected by inoperable HCC experiencing an incomplete response following ≥1 cycle of TAE/TAC.
问 AI
Like
Bookmark
Share
View Full Paper
问 AI
Like
Bookmark
Share
View Full Paper
Stereotactic Radiotherapy after Incomplete Transarterial (Chemo-) Embolization (TAE) versus Exclusive TAE or TACE for Treatment of Inoperable HCC: A Phase III Trial (NCT02323360) | Synapse